Carnitine and its derivatives have recently been shown to protect cardiac metabolism and function in ischemic heart disease and other clinical conditions of myocardial ischemia. Potential mechanisms of this effect include an increase in glucose metabolism, a reduction of toxic effects of long-chain acyl-CoA and acyl-carnitine in myocytes, an increase in coronary blood flow and anti-arrhythmic effect. It has also been shown that propionyl-L-carnitine which penetrates faster than carnitine into myocytes is effective in inhibiting production of free radicals. Beneficial effects of carnitine supplementation have been demonstrated under a variety of clinical conditions such as acute cardiac ischemia, during extracorporeal circulation, in carnitine-dependent cardiomyopathy as well as in patients with chronic circulatory failure and in cardiogenic shock. However, further studies are required before carnitine administration could be recommended as a routine procedure in ischemic heart disease or before cardiopulmonary bypass.
Introduction
and iron [3] is equally important. However, if the diet is deficient in carnitine, a considerable drop soon develops in L-Carnitine (b-hydroxy-g-trimethyl-amino-butyric acid) its plasma concentration [4] . Minimum supplementation of is a crucial component of activated fatty acids transport carnitine in the diet to maintain its body stores constant mechanism across the mitochondrial membrane [1] . Carranges from 8 to 11 mg per day [4] . The richest source of nitine facilitates oxidation of long-chain fatty acids, moducarnitine is red meat, which contains about 5.5 mmol / g of lates the ratio of CoA to CoA-SH, and is involved in tissue, and among plant-origin products -beans (0.72 trapping acyl residues from peroxisomes and mitochondria.
mmol / g) and avocado. Carnitine also participates in metabolism of branched chain
The total content of carnitine in the human body is about amino acids and stabilizes cellular membranes. It is also a 100 mmol (16 g) but it depends on the diet, muscle mass free radical scavenger and is likely to take part in control and the age [1] . Muscles contain 98% of that total amount, of nuclear transcription [1, 2] . The primary sites for carwhile 1.5 and 0.5% of carnitine are found in the liver and nitine synthesis from 6-N-trimethylolysine are the liver and other tissues, respectively [5] . The total carnitine conthe kidneys, although the brain does have a small potential centration in plasma is usually in the range of 42-85 as well. Substrates that are indispensable for carnitine mmol / l, and that of free carnitine in the range of 35-70 synthesis and are present in the diet are lysine and mmol / l [6] . Carnitine concentration in the heart is about methionine, although the presence of vitamins C and B , 4.2 mmol / g of tissue, which is over three times higher, 6 than that in the striated muscles (1.26 mmol / g), four times higher than that in the liver (0.94 mmol / g), and eight times higher than that in the kidney (0.52 mmol / g) [7] . The transferase 1 (CPT 1) which is located on the internal side skeletal muscles and the heart lack potential for synof the external mitochondrial membrane transfers activated thesizing carnitine.
long-chain acyl residues from acyl-CoA into carnitine. Accumulation of carnitine in the heart is facilitated by Carnitine translocase exchanges acyl-carnitine for carnitine active extraction of carnitine from plasma against a 60-fold from the matrix via the internal mitochondrial membrane. concentration gradient [8] . Unlike in the liver, carnitine
On the internal side of the inner mitochondrial membrane, concentration in the myocardium and skeletal muscle is carnitine palmitoyl transferase 2 (CPT 2) catalysis acylrelatively independent of its temporary supply [9] .
CoA synthesis from acyl-carnitine and matrix pool of Over 95% of ingested carnitine is excreted in urine in CoA-SH (Fig. 1) . Finally acyl-CoA undergoes mitochonhumans [10] . The clearance of free carnitine is about four drial b-oxidation with a release of energy in the ATP form. times lower than of acyl-carnitine (1.1 ml / min and 4.8 ml,
Carnitine lowers the ratio of intramitochondrial acyl-CoA 1 respectively). There is evidence that a Na dependent to CoA and causes detoxification of accumulated acyl-CoA system exists driven by energy from the ATP hydrolysis. It esters in patients with defective metabolism of glucose or is responsible for carnitine transport through the muscle acyl-oxidation. The above mechanism is impaired when cell membrane [11] . Carnitine transport to the mitochonmitochondrial b-oxidation disturbances develop in cardria is carried out by a specific protein carrier [12] . nitine deficient patients [15] . Long-chain fatty acids constitute a basic substrate for Systemic carnitine deficiency manifests mainly as a oxidative energy metabolism in the myocardium. Followdysfunction of skeletal muscles and myocardium, where ing transport through the cellular membrane, they undergo fatty acids constitute a basic energy substrate. Other activation to acyl-CoA in the cytoplasm or on the external symptoms of carnitine deficiency also include hypomitochondrial membrane. Though some of activated fatty glycemia due to exhaustion of glucose reserves, which is acids undergo esterification to triglycerides, majority bean alternative substrate to fatty acids, hyperammonemia, comes a substrate for b-oxidation in mitochondria. Carhypoketonemia, coma, seizures, and developmental renitine has a basic role in transporting activated fatty acids tardation, as well as the presence of lipid deposits in the from the cytoplasm into mitochondria, where b-oxidation histopathologic picture of the liver and muscles. Primary occurs. Short-and medium-chain fatty acids are transcarnitine deficiencies result from inborn defects in specific ported into the mitochondrial matrix without any carnitine proteins or in carnitine transferases. Secondary causes of assistance in the process. Long-chain fatty acid acyl groups L-carnitine deficiency include metabolic defects in fatty are transported exclusively as carnitine esters by a caracid oxidation, mitochondrial myopathy, prematurity, Lnitine carrier the translocase, which constitutes a transcarnitine deficiency in the diet, dialysis therapy, diabetes, membraneous protein in the inner mitochondrial membrane and inadequate absorption from the gastrointestinal tract. [13, 14] .
Studies on carnitine concentration can indicate either an The 'carnitine system' consists mainly of carnitine, absolute deficit of carnitine when its level drops below 20 carnitine acyl-transferases, translocase, and transporting mmol / l, or its relative deficit when the ratio of carnitine proteins located in plasma membranes. Carnitine palmitoyl esters to free carnitine is above 0.4 [11] . Absolute or relative carnitine deficits develop in chronic congestive sarcolemma results in a decrease of membrane rest-poheart failure, acute myocardial ischemia, diseases of tential. In consequence, spontaneous action potentials may peripheral blood vessels, diabetes, and disturbances of lipid appear along with a delayed depolarization of action metabolism. The clinical importance of carnitine in the potential [28] . treatment of circulatory disorders was first demonstrated in
In the study of Silverman et al. carnitine supple-1973 when its deficit was discovered in patients with lipid mentation had a positive and dose-dependent effect on cardiomyopathy and reduced fatty acid oxidation [16] .
preserving ventricle compliance and contractility of isAdditionally, carnitine administration has been proven chemic canine heart muscle, yet had no influence upon a clinically beneficial in other diseases characterized by decrease in ATP concentration induced by ischemia [25] . carnitine deficit that include, among others, ischemic
In another study, when oxygenated blood supply was cardiomyopathy and peripheral atherosclerosis [2] .
restored, no recovery of lipid oxidation was observed Positive clinical effects of carnitine administration were unless carnitine deficiency had been compensated [29] . also observed in nervous system degenerative diseases, According to Liedtke et al. reduced carnitine reserves in brain ischemia, chronic fatigue syndrome, Alzheimer's the myocardium strengthen the negative influence of lipids disease, and AIDS [17] [18] [19] . L-Carnitine in a long-term and particularly of free fatty acids, on heart metabolism supplementation has been shown to be beneficial to the [29] . The positive carnitine influence seen in acute myocarfunction of erythrocytes in hemodialysed patients [20] . dial ischemia was explained by limiting a decrease in Positive results of carnitine therapy are due to, among high-energy phosphates [30] and some improvement in others, oxidation of fatty acids, the process which is linked glucose oxidation and lactate extraction [31] . Basic metawith saving muscle glycogen reserves. A number of bolic effects of carnitine supplementation during ischemiatherapeutic effects possibly come from the interaction of reperfusion and its suggested clinical effects are presented carnitine and its derivatives with the elements of cellular in Fig. 2 . membranes [21] .
Following carnitine administration, some improvement Some improvement in the muscle blood supply after in relaxation was observed in rat hearts with increased carnitine supplementation has been related to vasodilatafterload [32] . However, when isolated rabbit hearts were ation. In diabetes, L-carnitine supplementation causes a studied, no improvement of contractility, heart rate, or decrease in triglyceride synthesis, a drop in the cellular coronary perfusion pressure was reported [32] . Broderick free fatty acids uptake, and the removal from organism of et al. demonstrated a more than two-fold increase in excessive long-chain carnitine esters, as well as increase in glucose metabolism after ischemia and reperfusion in rat glycolysis, oxidation of pyruvate, and improvement in heart preparations perfused with carnitine-enriched blood neuronal transmission [22] .
before the onset of ischemia [31] .
Disturbances of myocardial function and carnitine metabolism -experimental data
Carnitine is released from ischemic myocardium, and its concentration in the coronary sinus is proportional to the concentration of lactate [23, 24] . These changes are reflected by a change in the ratio of free carnitine to carnitine esters in the heart. Anoxia caused by myocardial ischemia has been experimentally proven to be associated with the depletion of carnitine reserves and accumulation of toxic metabolites of fatty acid esterification, in consequence of restricted fatty-acids mitochondrial b-oxidation [25] . The result is a decrease of ATP concentration in the heart [26] . After only a few minutes of ischemia, free fatty acids, long-chain acyl-CoA esters and acyl-carnitine are all increased several times above the control level [27] and, after half an hour of ischemia, the free carnitine in the heart drops by half [26] .
Long-chain acyl-carnitine esters are lipophylic and may readily damage membrane lipids and particularly, membrane bound enzymatic proteins [27] . This results in an increase of membrane fluidity and affects membrane ion A positive carnitine influence on myocardial metabolism ventricle function and in the time of survival in the groups during ischemia-reperfusion has been confirmed by intreated with L-carnitine [44, 45] . Application of propionylcreased ATP concentration in myocardium [33] . Another L-carnitine to volume-loaded rat hearts was associated with study demonstrated a beneficial effect of carnitine, added an improvement in ventricle function without a simultato cold cardioplegia, on the aorta flow velocity, the stores neous increase in oxygen consumption [46] . Schonekess et of ATP in myocardium, and the condition of mitochondria al. have reported an improvement in the function of in rat hearts after reperfusion [34] . L-Carnitine supplehypertrophied myocardium and an increase in carbohydrate mentation beside causing an increase in ATP concenoxidation in rats treated with propionyl-L-carnitine [47]. tration, was associated with a lower amount of toxic esters
Another study reported a decrease in mortality in hamsters [33] , and with some improvement of systolic and diastolic with cardiomyopathy treated with carnitine [48] . There function of diabetic rat hearts [35] . A similar therapy have also been contradictory reports, which presented a applied to a group of diabetes-free rats did not result in any positive influence of inhibiting endogenic carnitine synchange of heart function [35] . Experimental studies have thesis upon ischemic rat hearts [49] . In summary, relative demonstrated that in diabetic rats even a short-term myocardial carnitine deficiency is observed during iscarnitine supplementation caused an improvement of chemia and many experimental data suggest that some myocardial contractility after ischemia-reperfusion [36] .
negative metabolic and biologic effects of ischemia, as Administration of propionyl-L-carnitine to diabetic rats well as heart failure are alleviated by carnitine suppleprior to ischemia and reperfusion resulted in a more mentation. complete recovery of post-reperfusion contractility [23] .
In dogs without previous myocardial ischemia, supplementation of high carnitine doses was linked with a 3. Biological effects of carnitine and propionylconsiderable increase (60-100%) in coronary blood flow carnitine administration [37] . In the same study a substantial increase in stroke volume and dP/dt for the left ventricle was reported.
It has been suggested to treat metabolic dysfunction When dogs with myocardial infarction were studied, a resulting from carnitine deficiency not only by administer-50% lower ST elevation was observed in ECG, if Ling L-carnitine, but also its derivative -propionyl-Lcarnitine was administered after the onset of ischemia [38] .
carnitine (Table 1) . Some biologic properties of propionylIncubation of heart endothelium cells in a L-carnitine-rich L-carnitine suggest that beneficial clinical effects could be environment causes a better recovery of their proper enhanced when compared to L-carnitine. Propionyl-L-carfunction during post-ischemic reoxygenation [39] .
nitine has higher affinity for the plasma membrane transProtection of cell membranes and especially of memport system. It is more lipophylic and penetrates myocytes brane enzymes is a possible cause of electrophysiologic faster than L-carnitine [50] . Moreover, the propionyl changes and antiarrythmic effect of carnitine. Studies on residue of propionyl-L-carnitine can be metabolized to the dogs treated with L-carnitine in doses of 40 and 80 mg / kg / succinate, a substrate of citric acid cycle [51] . Propionyl-Lmin revealed a decrease in the heart rate by about 17 and carnitine has also protective properties for blood vessels 30%, respectively [31] . In canine heart preparations suband the energy reserves of ischemic striated muscles [52] . jected to ischemia, a considerable carnitine-induced de-L-Carnitine and propionyl-L-carnitine were shown to crease in the frequency of ventricular arrhythmia, includprotect the ischemic myocardium against oxidative stress, ing ventricular fibrillation was observed [40] . The authors which is one of the basic mechanisms leading to a postsuggested it might have been caused by limiting the ischemic myocardial dysfunction known as 'stunning' necrotic area rather than by direct antiarrythmic action. It [53] . Ferrari et al. have published interesting study conhas also been demonstrated that carnitine supplementation cerning the maintenance of oxidative phosphorylation and is connected to limiting heart rhythm disturbances that prevention of calcium ion influx into mitochondria during come from a high concentration of free fatty acids in dogs reperfusion of rabbit hearts treated with propionyl-L-car- [41] . Carnitine administration to perfused isolated preparanitine before the onset of ischemia [54] . Protection of the tions of guinea pig hearts has substantially lowered the heart against oxidative stress during reperfusion was incidence of arrhythmia resulting from ischemia and demonstrated after pre-ischemic administration of carnitine reperfusion [42] .
and its derivatives, particularly propionyl-L-carnitine [2]. Propionyl-L-carnitine was demonstrated to be able to Propionyl-L-carnitine does have a potential for inhibiting reduce the incidence of ventricle fibrillation during reoxyproduction of free hydroxyl radicals. Endothelial cellular genation after ischemia in isolated preparations of guinea membranes are better protected by propionyl-L-carnitine 21 31 pig hearts [43] . against Fe and Fe ions induced peroxide production, Positive results of treatment with carnitine were obthe protection being possibly due to ion chelating [39] . served in experimental heart failure. Both in guinea pigs
The protective effect of propionyl-L-carnitine in perand dogs subjected to the toxin of Corynebacterium fused rat hearts is dose-dependent and also depends on the diphtheriae an improvement was observed in the left time of administration, provided it is administered before by guest on May 25, 2015
Downloaded from Increased ATP concentration, decrease of longPositive and dose-dependent effect on Decreased mortality and the rate of chain fatty-acids esters in myocardium [33, 66] preserving ventricle compliance and contractility circulatory failure in acute myocardial of ischemic canine heart muscle [25] infarction [57] When added to cardioplegic solution, improved mitochondrial function in rat myocardium Improvement of systolic and diastolic function Decreased diameter of the left ventricle was observed after reperfusion [34] in diabetic rat hearts [35] in congestive heart failure [79] Substantial increase in glucose metabolism in In high doses -a considerable increase Increase in claudication distance [84] rat hearts after ischemia and reperfusion [31] in coronary blood flow in dogs [37] Necessary factor for recovery of lipid metabolism and oxidation of accumulated fatty-acids during reperfusion after ischemia [29] Propionyl-LProtection of endothelium against Better recovery of contractility after Increase in stroke volume in patients a carnitine free-radicals [39] reperfusion when administered to diabetic with myocardial ischemia [59] rats prior to ischemia [23] Increase in ejection fraction in Improvement of ventricular function congestive heart failure [76] Stabilization of plasmatic membranes [39] of volume-loaded rat hearts [46] Anaplerotic function-providing substrates Lower incidence of arrhythmia for citrate acid cycle [51] Improvement of hypertrophied rat in hemodialysed patients [63] myocardial function [47] Decreased incidence of ischemia-related Lower incidence of ventricular arrhythmia and ventricle fibrillation in arrhythmia in acute myocardial guinea pigs hearts [42] infarction [64] a Being an L-carnitine derivative, propionyl-L-carnitine also possesses all metabolic properties of L-carnitine.
post-ischemic reperfusion begins [55] . As suggested in the and magnesium [57] . Propionyl-L-carnitine used in doses study, propionyl-L-carnitine may also have a role in of 15 mg / kg caused a slight decrease in peripheral stabilizing plasma membranes and in lowering the purine vascular resistance in patients with stable coronary disease, release from the perfused rat heart [39] .
but due to a simultaneous increase in stroke volume, no From the accumulated results it seems that positive decrease in arterial blood pressure was observed [58] . biological effects observed after propionyl-L-carnitine are A similar dose administered to patients with ischemic more evident that after L-carnitine administration. Better heart disease caused in a short time (5 min) a 43% increase penetration into myocytes and supplying a substrate for the in lactate uptake by myocardium and increase in stroke citric acid cycle can explain this observation in short-term volume by 8% [59] . On the other hand, administration of supplementation. Inhibiting free-radicals generation and L-carnitine in a single dose of 40 mg / kg to patients with stabilizing plasma membranes may be other contributing stable coronary heart disease did not cause any change in factors.
the heart rate at rest or in systolic and diastolic arterial pressure [60] . Coronary artery sclerosis is particularly common in 4. Carnitine and circulatory diseases -clinical diabetic patients. Disturbances of myocardial contractility studies in diabetic patients are generally associated with a higher incidence of coronary heart disease in this population.
Ischemic heart disease
Many diabetics, however, suffer from decreased myocardial contractility in spite of negative coronarographic A decreased carnitine concentration in the heart was examinations. The causes of impaired heart contractility in observed in patients who died of myocardial infarction diabetic patients who present no changes detectable by [56] . In patients with acute myocardial infarction, a fourcoronarography include, among others, microangiopathy fold increase was observed in free carnitine elimination and metabolic disturbances. Carnitine deficiency is now and almost a two-fold increase in the elimination of shortthe best recognized condition of the latter. Decreased level chain carnitine esters by kidney [20] . Arsenian et al.
of free and total carnitine in diabetes, with a simultaneous demonstrated a decrease in mortality and incidence of increase in concentrations of long-chained acyl-CoA and circulatory failure in a group of patients with acute long-chain carnitine esters has been shown [23] . myocardial infarction, who were administered 3 g of Some correlation has been also demonstrated between carnitine along with solution of glucose, insulin, potassium the left ventricular contraction index and long-chain acylby guest on May 25, 2015 Downloaded from carnitine concentration in the myocardium during reperfusyndromes can be divided into systemic and myopathic in sion in patients after mitral valve replacement [61] . These nature. The former is characterized by a low carnitine data suggest, in line with the results of experimental concentration both in muscles and the blood, and the latter studies that carnitine and its derivatives protect human is known for a low carnitine concentration in muscles ischemic heart against oxidative stress not only by modifycoexisting with the proper carnitine concentration in blood. ing carnitine acyl-transferase activity and metabolic effect, This division enables assessment of the rationale for using but by other mechanisms as well [21] .
carnitine in the treatment of concurrent circulatory failure.
Cardiomyopathies that coexist with a low blood carnitine 4.2. Arrhythmia level are generally well treatable with carnitine [69, 70] . Myopathies and cardiomyopathies with proper blood carHeart electrophysiology after carnitine administration nitine concentration prevalently do have some acyl-CoA (30 mg per kg body weight over 3 min) did not show any dehydrogenase deficiency or functional disturbances of changes either in the conductivity time or in refraction carnitine transport proteins [71] . However, increased carperiod. The cycle duration in the sinus node was shortened nitine concentrations in blood have been also seen in by 5%, while the arterial blood pressure remained uncardiomyopathic patients [72] . In dilated cardiomyopathy changed [62] . It has been shown that the incidence of patients who underwent heart transplantation for circulatventricular and supraventricular arrhythmia could be limory failure, a low carnitine concentration was found both in ited during hemodialysis in chronic renal failure [63] . A the blood and myocardium [73] . Myocardial carnitine prolonged L-carnitine therapy in angina pectoris was concentration was also lower in rheumatic heart disease associated with a considerable decrease in the frequency of [74] . Administration of carnitine to children with ventricular arrhythmias [64] . Rizzon et al. noticed a diphtheria was found to have reduced substantially the statistically significant decrease of the frequency of venincidence of myocarditis [75] . One-month propionyl-Ltricular arrhythmia in a group of patients with acute carnitine therapy in doses of 1.5 g for 24 h in patients with myocardial infarction who were administered 100 mg of congestive heart failure resulted in an increased ejection carnitine per kg of body weight [65] . Although the studied fraction [76] . Hemodialysed patients were observed to groups of patients were small, L-carnitine administration to have a lower free-carnitine concentration in blood, despite patients with ischemic heart disease appears to be a normal concentration of total carnitine. After a 12-month promising therapy of ischemia-induced arrhythmia as carnitine therapy at 500 mg / 24 h dose the same patients potentially addressed to restoring of membrane rest-pohad improved circulatory function in electrocardiographic tential.
examination [77] . Pugliese et al. observed a decrease in pulmonary arterial 4.3. Cardiopulmonary bypass surgery pressure, in the heart rate in patients with hepatic cirrhosis after administration of 30 mg of L-carnitine per kilogram Oral administration of carnitine (1 g) for 2 days before body weight [78] . Both short-and long-term propionyl-Lthe coronary artery bypass graft (CABG) operation was carnitine supplementations, in patients with congestive associated with a higher ATP concentration and a more heart failure resulted in decreased pressure in the pulmonfavourable ratio of free carnitine to long-chain acyl-carary artery and the left ventricle diameter [79] . One study nitine in the atrial muscle [66] . Administration of high on patients with shock who were given high L-carnitine L-carnitine doses for 3 days prior to the extracorporeal doses did demonstrate clinical improvement [80] , while circulation was not linked to an improvement of hemoanother report concluded that a 12-h acetyl-carnitine dynamic parameters, although a biopsy of septum revealed administration to patients in shock was associated only a better preserved cellular ultrastructure [67] . On the other with a slight improvement in selected hemodynamic hand, in patients with a low ejection fraction a dose of 360 parameters [81] . mg of L-carnitine added to cardioplegia was demonstrated
In the light of these collected results, application of to have a positive influence on the stroke volume immedicarnitine appears promising in circulatory failure. Howately after weaning from extracorporeal circulation [68] . In ever, except for carnitine deficiency syndromes, this has patients after CABG, L-carnitine supplementation has been not been satisfactorily proven. shown to be associated with an increased uptake of free fatty acids by myocardium and with their lower con-4.5. Peripheral blood vessel diseases centration in blood [2] .
The data on the influence of carnitine and its derivatives 4.4. Circulatory failure in cases of peripheral blood vessel disease generally come from experimental studies. Accordingly, propionyl-carEarly reports on carnitine in the treatment of circulatory nitine has a potential for inhibiting thrombosis induced in failure were concerned with its application in cases of the rat's tail [82] . Corsico et al. observed the protective carnitine deficiency syndrome. Carnitine deficiency properties of propionyl-L-carnitine for the condition and by guest on May 25, 2015 Downloaded from function of muscles as well as the condition of vessels that administration in ischemic heart disease and before carwere damaged with sodium lauryl-sulphate [53] . Patients diopulmonary bypass surgery. with peripheral blood vessel disease were found to have on exertion an increased blood concentration of total carnitine as well as long-and short-chain acyl-carnitine [83] .
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